Refine
Has Fulltext
- yes (135)
Is part of the Bibliography
- yes (135)
Year of publication
Document Type
- Journal article (115)
- Doctoral Thesis (19)
- Other (1)
Language
- English (135) (remove)
Keywords
- Neisseria meningitidis (21)
- Echinococcus (10)
- Fuchsbandwurm (6)
- Tanzania (6)
- meningococcal disease (6)
- Aspergillus (4)
- Germany (4)
- antimicrobial resistance (4)
- neisseria meningitidis (4)
- stem cells (4)
- COVID-19 (3)
- Insulin (3)
- MRSA (3)
- Meningitis (3)
- Neisseria gonorrhoeae (3)
- SARS-CoV-2 (3)
- Serotonin (3)
- infection (3)
- inflammation (3)
- meningitis (3)
- multilocularis (3)
- ARONJ (2)
- Apoptosis (2)
- BDG (2)
- Brain endothelial cells (2)
- C5aR1 (2)
- Candida auris (2)
- Echinococcosis (2)
- Fusarium (2)
- Genregulation (2)
- Group B Streptococcus (2)
- HBMEC (2)
- Haemophilus influenzae (2)
- Helicobacter pylori (2)
- Komplement <Immunologie> (2)
- MITE (2)
- MLST (2)
- Rhizopus (2)
- Stem cell (2)
- Tapeworm (2)
- Ureaplasma parvum (2)
- Ureaplasma urealyticum (2)
- alveolar echinococcosis (2)
- antigen (2)
- antimicrobial stewardship (2)
- bacteria (2)
- bacterial meningitis (2)
- bacterial pathogens (2)
- benzimidazole (2)
- beta-D-glucan (2)
- blood–brain barrier (2)
- brain endothelial cells (2)
- candidemia (2)
- chemotherapy (2)
- colonization (2)
- comparative genomics (2)
- diagnosis (2)
- echinococcus multilocularis (2)
- flatworm (2)
- galactomannan (2)
- gene conversion (2)
- gene expression (2)
- genome sequencing (2)
- granulocytes (2)
- haemophilus influenzae (2)
- homologous recombination (2)
- host-pathogen interaction (2)
- infection control (2)
- men who have sex with men (2)
- microbiology (2)
- neuroinflammation (2)
- neutrophils (2)
- osteonecrosis of the jaw (2)
- osteoradionecrosis (2)
- outer membrane protein (2)
- pathogens (2)
- platyhelminthes (2)
- sepsis (2)
- sphingolipids (2)
- surgical site infection (2)
- tapeworm (2)
- transcriptome (2)
- 5-methyl cytosine (1)
- Abl (1)
- Acetylated tubulin (1)
- Adhäsine (1)
- Alkaline phosphatase (1)
- Alternaria (1)
- Anaphylatoxine (1)
- Anaphylatoxinrezeptoren (1)
- Argonaute (1)
- Ascaris lumbricoides (1)
- Aspergillus fumigatus (1)
- AurisID (1)
- B neisseria meningitidis (1)
- BacT/ALERT (1)
- Bacterial meningitis (1)
- Bakterielle Hirnhautentzündung (1)
- Bakterien (1)
- Bandwürmer (1)
- Benzimidazolderivate (1)
- Benzimidazoles (1)
- Biohazard (1)
- Blut-Liquor-Schranke (1)
- Brugia Malayi (1)
- C-reactive protein (1)
- C3a (1)
- C3aR (1)
- C5a (1)
- C5aR2 (1)
- CCL3 (1)
- CCL4 (1)
- CCL5 (1)
- COVID-19 testing (1)
- COVID‐19 (1)
- CPG binding domain (1)
- Calibration (1)
- Cancer treatment (1)
- Candida albicans (1)
- Candida lusitaniae (1)
- Caspase (1)
- Ceramide (1)
- Cestoda (1)
- Cestoda Taeniidae (1)
- Cestode (1)
- Chagas disease (1)
- Chemotherapie (1)
- Chemotherapy (1)
- Circinella (1)
- Clinical prediction rule (1)
- Colombia (1)
- Colonization (1)
- Community-acquired methicillin-resistant Staphylococcus aureus (1)
- Cyclo-AMP (1)
- DNA methylation (1)
- DNA recombination (1)
- Dendritic cell (1)
- Dendritische Zelle (1)
- Densovirus (1)
- Disaster response (1)
- Doxycycline (1)
- Doxyzyklin (1)
- ESBL (1)
- ET-15 clone (1)
- Echinokokkus (1)
- Efflux transport (1)
- Eingeweidewürmer (1)
- Elderly (1)
- EmERK (1)
- Emergence (1)
- Endosymbiont (1)
- Enterobacteriaceae (1)
- Entwicklung (1)
- Epigenetic (1)
- Escherichia coli K1 (1)
- Escherichia coli infections (1)
- Europe (1)
- Expansion microscopy (1)
- False positive reactions (1)
- FarR (1)
- Filariose (1)
- FinO family (1)
- Fks1 (1)
- Flagellin (1)
- Flagelline (1)
- Fox tapeworm (1)
- FoxQ2 (1)
- Fungiplex Candida Auris (1)
- GM (1)
- Genanalyse (1)
- Gene silencing (1)
- Genexpression (1)
- Genom-Vergleich (1)
- Geriatric care (1)
- Geriatrics (1)
- Germinative cell (1)
- Glutathione (1)
- Golgi (1)
- HFQ (1)
- HIV (1)
- Heilmittel (1)
- Helicobacter (1)
- Helminth (1)
- Helminths (1)
- Hfq (1)
- High throughput screening (1)
- Hirnendothelzellen (1)
- Hospital emergency plan (1)
- Host-parasite interaction (1)
- Host-pathogen interactions (1)
- I-lactate (1)
- IA (1)
- ICM (1)
- IDSA (1)
- IMD (1)
- IctP (1)
- Imatinib (1)
- Immunmodulation (1)
- Immunomodulation (1)
- In-vitro-Kultur (1)
- Inducible Clindamycin Resistance (1)
- Induzierte pluripotente Stammzelle (1)
- Infection control (1)
- Infektion (1)
- Inhibitor (1)
- Innate immunity (1)
- Jurkat cells (1)
- Kinase inhibitor (1)
- Komplement C3a (1)
- Komplement C5a (1)
- Konfokale Mikroskopie (1)
- LTR retrotransposons (1)
- Larvae (1)
- Leptomeningeal cells (1)
- Leptomeningealzellen (1)
- Lichtheimia (1)
- Listeria monocytogenes (1)
- MAP kinase (1)
- MAP-Kinase (1)
- MRONJ (1)
- MSIS (1)
- Mass critical care (1)
- Medicine (1)
- Medizin (1)
- Meningococcal infection (1)
- Meningococcal polysaccharide caccine (1)
- Meningococcal serogroup C (1)
- Meningococci (1)
- Meningokokken (1)
- Mesocestoides corti (1)
- Mesocestoides vogae (1)
- Metacestode (1)
- Methicillin resistant Staphylococcus aureus (1)
- Methicillin-resistant Staphylococcus aureus (1)
- Methicillin-resistant staphylococcus aureus (1)
- Mikrobiologie (1)
- Mobile genetic element (1)
- Mucin (1)
- Mucor (1)
- Mucorales (1)
- Multiplex PCR (1)
- Mwanza (1)
- Mycobacterium marinum (1)
- N-oleoyl serinol (1)
- NAS (1)
- NadA (1)
- Nanos (1)
- Nasal Carriage (1)
- Neisseria (1)
- Neisseria meningitdis (1)
- Neisseria meningitis (1)
- Neoblast (1)
- Nervous system (1)
- Neuroinfectiology (1)
- Neuroinflammation (1)
- Neuropeptide (1)
- Non-coding RNA (1)
- Nursing homes (1)
- ONJ (1)
- Onchozerkose (1)
- One Health (1)
- P-glycoprotein (1)
- P-gp (1)
- P. aeruginosa (1)
- PMNs (1)
- Parvovirus (1)
- Pathogenität (1)
- Pathogens (1)
- Pentastomiasis (1)
- Pneumococci (1)
- Predictive value of tests (1)
- Prevalence (1)
- ProQ (1)
- Proliferation (1)
- Protoscolex (1)
- Purpureocillium (1)
- RNA (1)
- RNA chaperone Hfq (1)
- Receptor kinase (1)
- Regulatorischer T-Lymphozyt (1)
- Regulatory T-cell (1)
- RelA (1)
- Rhizomucor (1)
- S. aureus (1)
- SARS‐CoV‐2 (1)
- SFRP (1)
- ST 772 (1)
- ST1797 (1)
- ST88 (1)
- Scedosporium (1)
- Schistosoma mansoni (1)
- Sequence motif analysis (1)
- Serum (1)
- Serumresistenz (1)
- Sierra Nevada (1)
- Signaltransduktion (1)
- Six3/6 Wnt (1)
- Skin (1)
- Small non-messenger RNS (1)
- Sphingolipide (1)
- Stammzelle (1)
- Staphylococcus aureus (1)
- Stem cells (1)
- Streptococcus agalactiae (1)
- Streptococcus suis (1)
- Stringent response (1)
- Stringente Antwort (1)
- Stringente Kontrolle (1)
- Supercoiling (1)
- Surgery (1)
- T Cells (1)
- T cells (1)
- TGF-BETA (1)
- TLR5 (1)
- TNF-alpha (1)
- Telomerase (1)
- Thioredoxin (1)
- Toll like Rezeptor 4 (1)
- Toll like receptor 4 (1)
- Transkription <Genetik> (1)
- Transkriptionsregulation (1)
- Transkriptomanalyse (1)
- Transposon (1)
- Tropheryma whipplei (1)
- Tuberculosis (1)
- Typisierung (1)
- Ureaplasma (1)
- Ureaplasma species (1)
- Vaccination (1)
- Valentine Leukocidin Genes (1)
- Vesicles (1)
- Virulenzfaktor (1)
- WBC (1)
- Whipple's disease (1)
- Wolbachia (1)
- Würmer (1)
- Xenopus oocytes (1)
- Zelldifferenzierung (1)
- Zellzyklus (1)
- Zink (1)
- Zinkmangel (1)
- acute watery diarrhea (1)
- admission screening (1)
- agar (1)
- agar diffusion test (1)
- alloSCT patients (1)
- alternative pig farming (1)
- alveoar echinococcosis (1)
- ampicillin (1)
- anaphylatoxin receptors (1)
- anaphylatoxins (1)
- angeborene Immunität (1)
- anidulafungin (1)
- antero-posterior axis (1)
- antibiotic bone concentration (1)
- antibiotic prescription behavior (1)
- antibiotic use (1)
- antibodies (1)
- anticoagulants (1)
- antifungal susceptibility (1)
- antifungals (1)
- antigen testing (1)
- antigen-B (1)
- antigens (1)
- antimicrobial (1)
- antimicrobials (1)
- antiresorptive drug-related osteonecrosis of the jaw (1)
- assay (1)
- attitude of health personnel (1)
- atypical chemokine receptor 3 (1)
- aureus infections (1)
- autochthonous infection (1)
- azole resistance (1)
- bactericidal activity (1)
- beta-lactam (1)
- beta-tubulin (1)
- beta‐d‐glucan (1)
- biological techniques (1)
- biomarker (1)
- biosynthesis (1)
- blood (1)
- blood fluke (1)
- blood stream infections (1)
- blood-brain barrier (1)
- blood-cerebrospinal fluid barrier (1)
- bloodstream infection (1)
- brain barrier (1)
- brain endothelial cell (1)
- breakthrough (1)
- bronchoalveolar lavage fluid (1)
- cAMP (1)
- campylobacteriosis (1)
- caspase-3 (1)
- caspofungin (1)
- cell staining (1)
- cell wall (1)
- cells (1)
- central-nervous-system (1)
- cephalosporin-resistant gram-negative bacteria (1)
- ceramide (1)
- ceramide analogs (1)
- cestodes (1)
- chaperone (1)
- chemical properties (1)
- children (1)
- chorioamnionitis (1)
- choroid-plexus (1)
- circulating (1)
- coagulase-negative staphylococci (1)
- commercial kits (1)
- community settings (1)
- complement system (1)
- complex (1)
- cord blood (1)
- corticosteroids (1)
- cryptic (1)
- cutibacteria (1)
- cytokines (1)
- dRNA-seq (1)
- dendritic cells (1)
- detection limits (1)
- development (1)
- differential age distribution (1)
- digital phenotyping (1)
- disease-associated (1)
- dual function (1)
- echinocandin (1)
- echinocandins (1)
- echinococcosis (1)
- ecological momentary assessment (1)
- ecology (1)
- efflux pumps (1)
- elucidation (1)
- endophthalmitis (1)
- endothelial cells (1)
- epgenetics (1)
- epidemiology (1)
- epidermal growth factor (1)
- epithelial cells (1)
- excretory-secretory (1)
- expert recommendation (1)
- extracellular (1)
- eye infection (1)
- factor H (1)
- feasibility study (1)
- field gel-electrophoreresis (1)
- flagella (1)
- flow cytometry (1)
- fluorescence microscopy (1)
- foxtapeworm (1)
- fungal antigens (1)
- fungal infection (1)
- fungal molecular diagnostics (1)
- fungi (1)
- fungicidal activity (1)
- galectin-2 (1)
- gangliosides and lipid rafts (1)
- gen (1)
- gene (1)
- general practice (1)
- general practitioner (1)
- generalized anxiety disorder (1)
- genetic loci (1)
- genetic variation (1)
- genetics (1)
- genome (1)
- genome comparison (1)
- genomic databases (1)
- genomic libraries (1)
- genomics (1)
- germinative cell (1)
- germinative cells (1)
- global regulators (1)
- globale Regulatoren (1)
- glucan synthase (1)
- glutamate dehydrogenase (1)
- glutathione (1)
- granulosus (1)
- group-B (1)
- helminth (1)
- helminths (1)
- hematopoietic stem cell transplantation (1)
- hemihepatectomy (1)
- hospital-acquired methicillin-resistant Staphylococcus aureus (1)
- host defense (1)
- host response (1)
- host-pathogen interactions (1)
- host–pathogen interaction (1)
- human brain microvascular endothelial cells (1)
- hydatid disease (1)
- hydrogels (1)
- hyphae (1)
- identification (1)
- imaging (1)
- immune evasion (1)
- immune impairment (1)
- immune response (1)
- immunology (1)
- immunomodulation (1)
- immunoprecipitation (1)
- immunotherapy (1)
- in vitro (1)
- in vivo (1)
- indigenous (1)
- induced pluripotent stem cells (1)
- infection prevention (1)
- infectious diseases management (1)
- innate immune evasions (1)
- innate immune response (1)
- insulin (1)
- interstage aspiration (1)
- intervention strategies (1)
- intravenous ceftriaxone (1)
- intravitreal vancomycin and amikacin (1)
- invasive aspergillosis (1)
- invasive disease (1)
- invasive meningococcal disease (1)
- invasive meningococcal diseases (1)
- invasive pulmonary aspergillosis (1)
- jaw bone (1)
- joint aspiration (1)
- joint infection (1)
- keratitis (1)
- killing (1)
- kinase (1)
- knowledge (1)
- laboratory techniques and procedures (1)
- larvae (1)
- leptomeningeal cells (1)
- leucocyte count (1)
- liver (1)
- liver resection (1)
- livestock-associated staphylococci (1)
- long noncoding RNA (1)
- longitudinal studies (1)
- mammalian genomics (1)
- mannan (1)
- marker (1)
- matrix metallopeptidase-1 (1)
- maximum liklihood (1)
- mebendazole (1)
- meningeal blood-csf barrier (1)
- meningococcal lineages (1)
- meningococcal polysaccharides (1)
- meningococci (1)
- meningococcus (1)
- metabolism (1)
- metacestode vesicles (1)
- metamorphosis (1)
- methyltransferase homolog (1)
- micafungin (1)
- mice (1)
- microRNA (1)
- microbial surface component recognising adhesive matrix molecules (1)
- microbiological culture (1)
- microbiology techniques (1)
- microscopy (1)
- microvascular endothelial cells (1)
- microvascular endothelial-cells (1)
- mitochondria (1)
- mitochondrial dynamics (1)
- mitochondrial morphology (1)
- mobile crowdsensing (1)
- mobile health (1)
- molecular characterization (1)
- molecular epidemiology (1)
- monoclonal antibody (1)
- monocytes (1)
- mouse model (1)
- mouse models (1)
- multifaceted approaches (1)
- multiple myeloma (1)
- mycobacterial infection (1)
- mycophenolic acid (1)
- myocyte (1)
- natamycin (1)
- natural killer cell (1)
- natural transformation (1)
- neglected diseases (1)
- neglected groups (1)
- nematodes (1)
- neoblast (1)
- neonatal morbidity (1)
- niche adaptation (1)
- nitrite respiration (1)
- nitrites (1)
- non-aureus staphylococci (1)
- nonautonomous (1)
- nosocomial transmission (1)
- nuclear magnetic resonance (1)
- ocular infection (1)
- one-health approach (1)
- oral cefpodoxime (1)
- oral doxycycline (1)
- oral microbiome (1)
- organic farming (1)
- outpatient (1)
- oxidative stress (1)
- panton-valentine leukocidin (1)
- paradoxical effect (1)
- paradoxical growth (1)
- parasitic diseases (1)
- pathometabolism (1)
- pediatric (1)
- pediatrician (1)
- periprosthetic joint infection (1)
- phase variation (1)
- phylotypic (1)
- pig farming methods (1)
- piperacillin (1)
- piperacillin/tazobactam (1)
- planarian (1)
- plexus epithelial-cells (1)
- pluripotency (1)
- polymorphonuclear neutrophils (1)
- population biology (1)
- population genetics (1)
- post-operative antibiotic treatment (1)
- primary care (1)
- primary cells (1)
- probe-based real-time PCR (1)
- protein kinases (1)
- proteins (1)
- proteomic analysis (1)
- public health (1)
- qPCR (1)
- real-time PCR (1)
- recombinant proteins (1)
- regulation (1)
- regulator (1)
- regulatory T cells (1)
- relA (1)
- resistance (1)
- retrotransposition (1)
- revision arthroplasty (1)
- schistoma mansoni (1)
- sensitivity (1)
- sensitivity and specificity (1)
- septic (1)
- sequence (1)
- sequence assembly tools (1)
- serogroup B (1)
- serogroup-Y (1)
- serology (1)
- seroprevalence (1)
- serum (1)
- serum resistance (1)
- signaltransduction (1)
- single-molecule tracking (1)
- sirolimus (1)
- small RNA (1)
- small interfering RNAs (1)
- spa typing (1)
- sporidia (1)
- state-based model (1)
- stem cell transplantation (1)
- strain MC58 (1)
- strain specificity (1)
- stringent response (1)
- structural determination (1)
- super-resolution microscopy (1)
- surgical intra-abdominal infections (1)
- survey (1)
- systems biology (1)
- taxonomy (1)
- tazobactam (1)
- testing strategy (1)
- therapy (1)
- throat (1)
- tight junctions (1)
- topic ofloxacin (1)
- transcription factors (1)
- transcriptional regulation (1)
- transcriptome data analysis (1)
- transplantation (1)
- transposable elements (1)
- typing (1)
- under five children (1)
- upper extremity (1)
- utilization (1)
- vaccine development (1)
- vaccines (1)
- vesicles (1)
- viral load (1)
- virulence (1)
- virulenceregulatory evolution (1)
- vitrectomy (1)
- water microbiology (1)
- white blood cell count (1)
- whole blood ex vivo model (1)
- whole-blood infection assay (1)
- whole-blood model (1)
- zinc cluster transcription factor (1)
- zinc limitation (1)
- γ-glutamyl cycle (1)
Institute
- Institut für Hygiene und Mikrobiologie (135) (remove)
Sonstige beteiligte Institutionen
- Department of Hematology and Oncology, Sana Hospital Hof, Hof, Germany (1)
- Department of Laboratory Medicine and Medicine Huddinge, Karolinska Institutet and University Hospital, Stockholm, Sweden (1)
- Department of Medicine A, University Hospital of Münster, Münster, Germany (1)
- Instituto de Higiene, Universidad de la República, Montevideo, Uruguay (1)
- Instituto de Hygiene Montevideo, Uruguay (1)
- Krankenhaushygiene und Antimicrobial Stewardship (1)
- Krankenhaushygiene und Antimicrobial Stewardship (Universitätsklinikum) (1)
- Research Center for Infectious Diseases (ZINF), University of Würzburg, Würzburg, Germany (1)
EU-Project number / Contract (GA) number
- 2016 FGR 0053 (1)
- 278864 (1)
Neisseria meningitidis (the meningococcus) is one of the major causes of bacterial meningitis, a life-threatening inflammation of the meninges. Traversal of the meningeal blood-cerebrospinal fluid barrier (mBCSFB), which is composed of highly specialized brain endothelial cells (BECs), and subsequent interaction with leptomeningeal cells (LMCs) are critical for disease progression. Due to the human-exclusive tropism of N. meningitidis, research on this complex host-pathogen interaction is mostly limited to in vitro studies. Previous studies have primarily used peripheral or immortalized BECs alone, which do not retain relevant barrier phenotypes in culture. To study meningococcal interaction with the mBCSFB in a physiologically more accurate context, BEC-LMC co-culture models were developed in this project using BEC-like cells derived from induced pluripotent stem cells (iBECs) or hCMEC/D3 cells in combination with LMCs derived from tumor biopsies.
Distinct BEC and LMC layers as well as characteristic expression of cellular markers were observed using transmission electron microscopy (TEM) and immunofluorescence staining. Clear junctional expression of brain endothelial tight and adherens junction proteins was detected in the iBEC layer. LMC co-culture increased iBEC barrier tightness and stability over a period of seven days, as determined by sodium fluorescein (NaF) permeability and transendothelial electrical resistance (TEER). Infection experiments demonstrated comparable meningococcal adhesion and invasion of the BEC layer in all models tested, consistent with previously published data. While only few bacteria crossed the iBEC-LMC barrier initially, transmigration rates increased substantially over 24 hours, despite constant high TEER. After 24 hours of infection, deterioration of the barrier properties was observed including loss of TEER and altered expression of tight and adherens junction components. Reduced mRNA levels of ZO-1, claudin-5, and VE-cadherin were detected in BECs from all models. qPCR and siRNA knockdown data suggested that transcriptional downregulation of these genes was potentially but not solely mediated by Snail1. Immunofluorescence staining showed reduced junctional coverage of occludin, indicating N. meningitidis-induced post-transcriptional modulation of this protein, as previous studies have suggested. Together, these results suggest a potential combination of transcellular and paracellular meningococcal traversal of the mBCSFB, with the more accessible paracellular route becoming available upon barrier disruption after prolonged N. meningitidis infection. Finally, N. meningitidis induced cellular expression of pro-inflammatory cytokines and chemokines such as IL-8 in all mBCSFB models. Overall, the work described in this thesis highlights the usefulness of advanced in vitro models of the mBCSFB that mimic native physiology and exhibit relevant barrier properties to study infection with meningeal pathogens such as N. meningitidis.
Background
Haemophilus influenzae (Hi) is a Gram-negative bacterium that may cause sepsis or meningitis, treatment of which mainly includes β-lactam antibiotics. Since 2019 EUCAST breakpoints for piperacillin/tazobactam have been available. Little is known about the prevalence and mechanisms of piperacillin/tazobactam resistance in Hi.
Objectives
To provide reliable prevalence data for piperacillin/tazobactam resistance in Hi in Germany, to evaluate different antibiotic susceptibility testing methods and to examine possible resistance mechanisms.
Methods
According to EUCAST breakpoints, the MIC for piperacillin/tazobactam resistance is >0.25 mg/L. All invasive Hi in Germany from 2019 were examined by gradient agar diffusion (GAD) for piperacillin/tazobactam susceptibility. Piperacillin/tazobactam broth microdilution (BMD), piperacillin GAD on tazobactam-containing agar [piperacillin GAD on Mueller–Hinton agar with horse blood (MH-F)/tazobactam) and piperacillin/tazobactam agar dilution (AD) were used for confirmation. Phenotypic testing was complemented by ftsI sequencing.
Results
Piperacillin/tazobactam GAD resulted in 2.9% (21/726) resistant Hi. BMD did not confirm piperacillin/tazobactam resistance. Two strains were found resistant by AD, of which one was also resistant using piperacillin GAD on MH-F/tazobactam. Overall, we found two strains with a piperacillin/tazobactam MIC >0.25 mg/L in at least two different tests (0.3%). Both were β-lactamase-producing amoxicillin/clavulanate-resistant with PBP3 mutations characterized as group III-like+. Relevant PBP3 mutations occurred in six strains without phenotypic piperacillin/tazobactam resistance. These mutations suggest a reduced efficacy of β-lactam antibiotics in these isolates.
Conclusions
Piperacillin/tazobactam resistance prevalence in invasive Hi is low in Germany. Reduced susceptibility was correlated with PBP3 mutations, in particular with group III mutations.
Non-aureus staphylococci (NAS) are ubiquitous bacteria in livestock-associated environments where they may act as reservoirs of antimicrobial resistance (AMR) genes for pathogens such as Staphylococcus aureus. Here, we tested whether housing conditions in pig farms could influence the overall AMR-NAS burden. Two hundred and forty porcine commensal and environmental NAS isolates from three different farm types (conventional, alternative, and organic) were tested for phenotypic antimicrobial susceptibility and subjected to whole genome sequencing. Genomic data were analysed regarding species identity and AMR gene carriage. Seventeen different NAS species were identified across all farm types. In contrast to conventional farms, no AMR genes were detectable towards methicillin, aminoglycosides, and phenicols in organic farms. Additionally, AMR genes to macrolides and tetracycline were rare among NAS in organic farms, while such genes were common in conventional husbandries. No differences in AMR detection existed between farm types regarding fosfomycin, lincosamides, fusidic acid, and heavy metal resistance gene presence. The combined data show that husbandry conditions influence the occurrence of resistant and multidrug-resistant bacteria in livestock, suggesting that changing husbandry practices may be an appropriate means of limiting the spread of AMR bacteria on farms.
Echinococcosis is an important zoonosis. The causative agent of Alveolar Echinococcosis (AE) is Echinococcus multilocularis. The treatment of human AE is limited to surgery and chemotherapy with albendazole (ABZ). However, ABZ works only parasitostatically and it needs to be taken for long periods, although it causes adverse side effects. Thus, development of new, parasiticidal drug with selective toxicity is required. Because undifferentiated stem cells of E. multilocularis play key role in its longevity and regenerative capacity, targeting stem cells is especially important.
In vitro screening of protein kinases inhibitors demonstrated that human PIM kinases inhibitors have detrimental effects on E. multilocularis. Through yeast two hybrid assay, the interaction of parasite PIM kinase (EmPIM) and its CDC25 (EmCDC25) was indicated. Through in situ hybridization, expression of EmPIM in the stem cells was observed. Therefore, EmPim is likely to be a positive regulator of cell cycle progression, the same as human Pim1. In addition, 20 compounds against EmPIM were selected through in silico screening and synthesized. One of them has a detrimental effect on E.multilocularis comparable to human pan-PIM inhibitors, but has much weaker toxicity on human cell lines.
Furthermore, triclabendazole (TCBZ) and its metabolite TCBZSX, which are approved for another flatworm disease, Fascioliasis were tried on E. multilocularis. With two stem cell markers, damage to stem cells by TCBZSX was shown. In addition, primary cells from treated vesicles never regenerated and the damage to stem cells proved to be irreversible.
Our in silico screening method used in EmPIM research has potential to identify compounds which overcome the side effect problem in ABZ-based chemotherapy. On the other hand, it is expected that my research of TCBZ can lead to development of a practical parasiticidal chemotherapy by combining TCBZ, which damages stem cells, and ABZ, which damages differentiated cells.
Alveolar (AE) and cystic (CE) echinococcosis are two parasitic diseases caused by the tapeworms Echinococcus multilocularis and E. granulosus sensu lato (s. l.), respectively. Currently, AE and CE are mainly diagnosed by means of imaging techniques, serology, and clinical and epidemiological data. However, no viability markers that indicate parasite state during infection are available. Extracellular small RNAs (sRNAs) are short non-coding RNAs that can be secreted by cells through association with extracellular vesicles, proteins, or lipoproteins. Circulating sRNAs can show altered expression in pathological states; hence, they are intensively studied as biomarkers for several diseases. Here, we profiled the sRNA transcriptomes of AE and CE patients to identify novel biomarkers to aid in medical decisions when current diagnostic procedures are inconclusive. For this, endogenous and parasitic sRNAs were analyzed by sRNA sequencing in serum from disease negative, positive, and treated patients and patients harboring a non-parasitic lesion. Consequently, 20 differentially expressed sRNAs associated with AE, CE, and/or non-parasitic lesion were identified. Our results represent an in-depth characterization of the effect E. multilocularis and E. granulosus s. l. exert on the extracellular sRNA landscape in human infections and provide a set of novel candidate biomarkers for both AE and CE detection.
The human specific gram-negative bacterium Neisseria meningitidis (Nme, meningococci) is a common colonizer of the upper respiratory tract. Upon becoming invasive, Nme can cause meningitis and life-threatening sepsis. The most important immune defense mechanism in invasive meningococcal disease (IMD) is the complement mediated killing of bacteria. The complement cascade is activated through different pathogen associated patterns and finally leads to the lysis of the bacteria by the membrane attack complex. In addition to the direct bacterial killing, the complement system is also an important player in different inflammatory processes. A hallmark of IMD is an overreaction of the immune system and the release of the potent anaphylatoxins C3a and C5a by the complement system is an important factor hereby. There are three anaphylatoxin receptors (ATRs), the C3aR, the C5aR1 and the C5aR2, capable of detecting these anaphylatoxins. It has already been shown that blocking the ATR C5aR1 strongly benefitted the outcome of IMD in a murine sepsis model. However, the roles of ATRs C3aR and C5aR2 in IMD are still unclear. This work aims to analyze the role of these ATRs in meningococcal sepsis and to identify possible underlying mechanisms. Furthermore, a possible involvement of the complement system, the ATRs and the type II CRISPR/Cas system on nasopharyngeal colonization is analyzed.
In vivo depletion experiments showed that without neutrophils or monocytes/macrophages the complement system alone was not able to clear a low dose Nme infection, which highlights the importance of cellular components in IMD. Analyzing the role of the ATRs in knock-out mice with high dose Nme infections, revealed that the lack of C5aR2, like the lack of C5aR1, was beneficial for the outcome of meningococcal induced sepsis. In contrast, the lack of C3aR in knock-out mice was detrimental. The positive outcome associated with the C5aRs could be reproduced by using an antagonist against both C5aRs or an antagonist specifically against C5aR1 in WT mice. These findings are giving hope to future therapeutic applications. Next, a possible contribution of neutrophils to this positive outcome was analyzed. Absence of C5aR1 led to a decrease of degranulation by neutrophils in a murine whole blood model, while the other ATRs showed no effect. Neutrophil analysis in human whole blood, on the other hand, revealed a reduced oxidative burst and IL-8 secretion upon inhibition of all three ATRs. A functional difference between the C5aRs and the C3aR in neutrophils was observed in phagocytosis, which was reduced upon C3aR inhibition, but was unaltered with C5aR1 or C5aR2 inhibition. Possible underlying mechanisms in the phosphorylation of ERK1/2 were analyzed in bone marrow derived macrophages isolated from ATR knock-out mice. The later phosphorylation of ERK1/2 in macrophages without C5aR1 or C5aR2 expression might explain, why blocking the C5aRs is beneficial for the outcome of IMD in mice. In contrast to these findings, the colonization of the nasopharynx in huCEACAM 1 expressing mice by Nme did not seem to depend on the Complement system factors C3 and C5 nor the ATRs. Additionally, no difference in the colonization could be observed in this model using Nme mutants lacking different parts of the type 2 CRISPR/Cas system.
Conclusively, this work highlights the importance of the complement system, the ATRs and the cellular components in IMD. Contrariwise, these factors did not play a role in the analyzed nasopharyngeal infection model. The beneficial effects of C5aR1 and C5aR2 lack/inhibition in IMD might have medicinal applications, which could support the standard therapies of IMD in the future.
Candida auris was first described as a yeast pathogen in 2009. Since then, the species has emerged worldwide. In contrast to most other Candida spp., C. auris frequently exhibits multi-drug resistance and is readily transmitted in hospital settings. While most detections so far are from colonised patients, C. auris does cause superficial and life-threatening invasive infections. During management of the first documented C. auris transmission in a German hospital, experts from the National Reference Centers for Invasive Fungal Infections (NRZMyk) and the National Reference Center for Surveillance of Nosocomial Infections screened available literature and integrated available knowledge on infection prevention and C. auris epidemiology and biology to enable optimal containment. Relevant recommendations developed during this process are summarised in this guidance document, intended to assist in management of C. auris transmission and potential outbreak situations. Rapid and effective measures to contain C. auris spread require a multi-disciplinary approach that includes clinical specialists of the affected unit, nursing staff, hospital hygiene, diagnostic microbiology, cleaning staff, hospital management and experts in diagnostic mycology / fungal infections. Action should be initiated in a step-wise process and relevant interventions differ between management of singular C. auris colonised / infected patients and detection of potential C. auris transmission or nosocomial outbreaks.
Background
PCR testing is considered the gold standard for SARS-CoV-2 diagnosis but its results are earliest available hours to days after testing. Rapid antigen tests represent a diagnostic tool enabling testing at the point of care. Rapid antigen tests have mostly been validated by the manufacturer or in controlled laboratory settings only. External validation at the point of care, particularly in general practice where the test is frequently used, is needed. Furthermore, it is unclear how well point of care tests are accepted by the practice staff.
Methods
In this prospective multicenter validation study in primary care, general practitioners included adult individuals presenting with symptoms suggesting COVID-19. Each patient was tested by the general practitioner, first with a nasopharyngeal swab for the point of care test (Roche SARS-CoV-2 Rapid Antigen Test) and then with a second swab for PCR testing. Using the RT-PCR result as a reference, we calculated specificity, sensitivity, positive predictive value and negative predictive value, with their 95% confidence intervals. General practitioners and medical assistants completed a survey to assess feasibility and usefulness of the point of care tests.
Results
In 40 practices in Würzburg, Germany, 1518 patients were recruited between 12/2020 and 06/2021. The point of care test achieved a sensitivity of 78.3% and a specificity of 99.5% compared to RT-PCR. With a prevalence of 9.5%, the positive predictive value was 93.9% and the negative predictive value was 97.8%. General practitioners rated the point of care test as a helpful tool to support diagnostics in patients with signs and symptoms suggestive for infection, particularly in situations where decision on further care is needed at short notice.
Conclusion
The point of care test used in this study showed a sensitivity below the manufacturer’s specification (Sensitivity 96.25%) in the practice but high values for specificity and high positive predictive value and negative predictive value. Although widely accepted in the practice, measures for further patient management require a sensitive interpretation of the point of care test results.
Despite available diagnostic tests and recent advances, diagnosis of pulmonary invasive aspergillosis (IPA) remains challenging. We performed a longitudinal case-control pilot study to identify host-specific, novel, and immune-relevant molecular candidates indicating IPA in patients post allogeneic stem cell transplantation (alloSCT). Supported by differential gene expression analysis of six relevant in vitro studies, we conducted RNA sequencing of three alloSCT patients categorized as probable IPA cases and their matched controls without Aspergillus infection (66 samples in total). We additionally performed immunoassay analysis for all patient samples to gain a multi-omics perspective. Profiling analysis suggested LGALS2, MMP1, IL-8, and caspase-3 as potential host molecular candidates indicating IPA in investigated alloSCT patients. MMP1, IL-8, and caspase-3 were evaluated further in alloSCT patients for their potential to differentiate possible IPA cases and patients suffering from COVID-19-associated pulmonary aspergillosis (CAPA) and appropriate control patients. Possible IPA cases showed differences in IL-8 and caspase-3 serum levels compared with matched controls. Furthermore, we observed significant differences in IL-8 and caspase-3 levels among CAPA patients compared with control patients. With our conceptual work, we demonstrate the potential value of considering the human immune response during Aspergillus infection to identify immune-relevant molecular candidates indicating IPA in alloSCT patients. These human host candidates together with already established fungal biomarkers might improve the accuracy of IPA diagnostic tools.
Background
Bacterial meningitis is a life-threatening disease that occurs when pathogens such as Neisseria meningitidis cross the meningeal blood cerebrospinal fluid barrier (mBCSFB) and infect the meninges. Due to the human-specific nature of N. meningitidis, previous research investigating this complex host–pathogen interaction has mostly been done in vitro using immortalized brain endothelial cells (BECs) alone, which often do not retain relevant barrier properties in culture. Here, we developed physiologically relevant mBCSFB models using BECs in co-culture with leptomeningeal cells (LMCs) to examine N. meningitidis interaction.
Methods
We used BEC-like cells derived from induced pluripotent stem cells (iBECs) or hCMEC/D3 cells in co-culture with LMCs derived from tumor biopsies. We employed TEM and structured illumination microscopy to characterize the models as well as bacterial interaction. We measured TEER and sodium fluorescein (NaF) permeability to determine barrier tightness and integrity. We then analyzed bacterial adherence and penetration of the cell barrier and examined changes in host gene expression of tight junctions as well as chemokines and cytokines in response to infection.
Results
Both cell types remained distinct in co-culture and iBECs showed characteristic expression of BEC markers including tight junction proteins and endothelial markers. iBEC barrier function as determined by TEER and NaF permeability was improved by LMC co-culture and remained stable for seven days. BEC response to N. meningitidis infection was not affected by LMC co-culture. We detected considerable amounts of BEC-adherent meningococci and a relatively small number of intracellular bacteria. Interestingly, we discovered bacteria traversing the BEC-LMC barrier within the first 24 h post-infection, when barrier integrity was still high, suggesting a transcellular route for N. meningitidis into the CNS. Finally, we observed deterioration of barrier properties including loss of TEER and reduced expression of cell-junction components at late time points of infection.
Conclusions
Here, we report, for the first time, on co-culture of human iPSC derived BECs or hCMEC/D3 with meningioma derived LMCs and find that LMC co-culture improves barrier properties of iBECs. These novel models allow for a better understanding of N. meningitidis interaction at the mBCSFB in a physiologically relevant setting.